Reactive Impurities in Excipients: Profiling, Identification and Mitigation of Drug–Excipient Incompatibility

No abstract is available for this paper.

• Publication year

  2011

• Venue

  AAPS PharmSciTech

• Publication date

  2011-09-27

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1208/s12249-011-9677-zPMID 21948318PMCID PMC3225520
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Handbook of Pharmaceutical Excipients

  2012cited by this paper
• An active film-coating approach to enhance chemical stability of a potent drug molecule

  2012cited by this paper
• Quantitative study of solid-state acid-base reactions between polymorphs of flufenamic acid and magnesium oxide using X-ray powder diffraction.

  2010cited by this paper
• Developing solid oral dosage forms: pharmaceutical theory and practice, Y. Qiu, Y. Chen, G.G.Z. Zhang, L. Liu, W. Porter. Elsevier (2009). 978 pp., 155 €, ISBN: 978-0-444-53242-8

  2010cited by this paper
• Reaction between drug substances and pharmaceutical excipients: formation of esters between cetirizine and polyols.

  2010cited by this paper
• Understanding drug-excipient compatibility: Oxidation of compound A in a solid dosage form

  2009cited by this paper
• Chapter 6 – Excipient Compatibility

  2009cited by this paper
• Update on genotoxicity and carcinogenicity testing of 472 marketed pharmaceuticals.

  2009cited by this paper
• The effect of crosslinker structure upon the rate of hydroperoxide formation in dried, crosslinked poly(vinylpyrrolidone)

  2008cited by this paper
• pH control of nucleophilic/electrophilic oxidation.

  2008influential reference
• The nitrate–nitrite–nitric oxide pathway in physiology and therapeutics

  2008cited by this paper
• Mechanoradical-Induced Degradation in a Pharmaceutical Blend during High-Shear Processing

  2008cited by this paper
• Lactose Contaminant as Steroid Degradation Enhancer

  2008cited by this paper
• Identification and Control of a Degradation Product in Avapro™ Film-Coated Tablet: Low Dose Formulation

  2008cited by this paper
• N-methylation and N-formylation of a secondary amine drug (varenicline) in an osmotic tablet.

  2008cited by this paper
• Risk-benefit health assessment of food - Food fortification and nitrate in vegetables

  2008cited by this paper
• Evaluation of hydroperoxides in common pharmaceutical excipients.

  2007cited by this paper
• Furfural and Derivatives

  2007cited by this paper
• Genotoxic and carcinogenic risk to humans of drug-nitrite interaction products.

  2007cited by this paper
• Detection and quantification of low-molecular-weight aldehydes in pharmaceutical excipients by headspace gas chromatography.

  2006cited by this paper
• Simultaneous determination of formic acid and formaldehyde in pharmaceutical excipients using headspace GC/MS.

  2006influential reference
• Removal of peroxides in polyethylene glycols by vacuum drying: Implications in the stability of biotech and pharmaceutical formulations

  2006cited by this paper
• Urea- Hydrogen Peroxide (UHP) Oxidation of Thiols to the Corresponding Disulfides Promoted by Maleic Anhydride as Mediator

  2005cited by this paper
• Effect of milling and compression on the solid-state Maillard reaction.

  2005cited by this paper
• Purification of Pharmaceutical Excipients with Supercritical Fluid Extraction

  2005cited by this paper
• Identification and quantitation of extractables from cellulose acetate butyrate (CAB) and estimation of their in vivo exposure levels.

  2004cited by this paper
• Is it the Method or the Process—Separating the Causes of Low Recovery

  2004cited by this paper
• Influence of Formaldehyde Impurity in Polysorbate 80 and PEG‐300 on the Stability of a Parenteral Formulation of BMS‐204352: Identification and Control of the Degradation Product

  2004cited by this paper
• Applications of Oxygen Polarography to Drug Stability Testing and Formulation Development: Solution-Phase Oxidation of Hydroxymethylglutaryl Coenzyme A (HMG-CoA) Reductase Inhibitors

  2004cited by this paper
• A New Approach to Accelerated Drug-Excipient Compatibility Testing

  2003cited by this paper
• The role of excipients and package components in the photostability of liquid formulations.

  2003cited by this paper
• Liquid chromatographic determination of residual hydrogen peroxide in pharmaceutical excipients using platinum and wired enzyme electrodes.

  2003cited by this paper
• A new model for predicting moisture uptake by packaged solid pharmaceuticals.

  2003cited by this paper
• The role of Fe3+ on Fe2+-dependent lipid peroxidation in phospholipid liposomes.

  2002cited by this paper
• Use of Oxygen Scavengers to Stabilize Solid Pharmaceutical Dosage Forms: A Case Study

  2002cited by this paper
• Oxidative degradation of pharmaceuticals: theory, mechanisms and inhibition.

  2001influential reference
• Catalytic Oxidative Deformylation of Polyethylene Glycols with the Participation of Molecular Oxygen

  2001cited by this paper
• The Effects of Residual Water on Solid State Stability of Drugs and Drug Products

  2001cited by this paper
• In vitro reaction of formaldehyde with fenfluramine: conversion to N-methyl fenfluramine.

  2001cited by this paper
• Effect of salt form on chemical stability of an ester prodrug of a glycoprotein IIb/IIIa receptor antagonist in solid dosage forms.

  2001cited by this paper
• Application of sorption--desorption moisture transfer modeling to the study of chemical stability of a moisture sensitive drug product in different packaging configurations.

  2001cited by this paper
• Influence of Peroxide Impurities in Povidone and Crospovidone on the Stability of Raloxifene Hydrochloride in Tablets: Identification and Control of an Oxidative Degradation Product

  2000cited by this paper
• Fats and Fatty Oils

  2000cited by this paper
• Chemical stability of an ester prodrug of a glycoprotein IIb/IIIa receptor antagonist in solid dosage forms.

  1999cited by this paper
• Tablet Dissolution Affected by a Moisture Mediated Solid-State Interaction Between Drug and Disintegrant

  1999cited by this paper
• Maillard reaction of lactose and fluoxetine hydrochloride, a secondary amine.

  1998influential reference
• Studies of reactions within molecular complexes: alkaline hydrolysis of substituted phenyl benzoates in the presence of xanthines

  1998cited by this paper
• Adsorption of ketotifen onto some pharmaceutical excipients

  1997cited by this paper
• Characterization of a Solid State Reaction Product from a Lyophilized Formulation of a Cyclic Heptapeptide. A Novel Example of an Excipient-Induced Oxidation

  1996cited by this paper
• Interactions between drug substances and excipients. 1. Fluorescence and HPLC studies of triazolophthalazine derivatives from hydralazine hydrochloride and starch.

  1996cited by this paper
• Degradation of polyethylene glycol. A study of the reaction mechanism in a model molecule: Tetraethylene glycol

  1996influential reference
• Polym. Degrad. Stab.

  1996cited by this paper
• Studies on the influence of pH and pancreatin on 13C-formaldehyde-induced gelatin cross-links using nuclear magnetic resonance.

  1996cited by this paper
• Photolytic and oxidative degradation of an antiemetic agent, RG 12915

  1995cited by this paper
• Effects of different types of lactose and disintegrant on dissolution stability of hydrochlorothiazide capsule formulations

  1994cited by this paper
• Mechanism of Optical Isomerization of(S)-N-[1-(2-Fluorophenyl)-3,4,6,7-tetrahydro-4-oxopyrrolo[3,2,1-jk] [l,4]-benzodiazepine-3-y1]-1H-indole-2-carboxamide (FK480) in Soft Capsules Containing Polyethylene Glycol 400 and Glycerol

  1994cited by this paper
• Handbook of Pharmaceutical Excipients

  1994cited by this paper
• Effect of 2-hydroxypropyl-β-cyclodextrin on the stability of prostaglandin E2 in solution

  1994cited by this paper
• Investigation into the yellowing on aging of sabril® tablet cores

  1994cited by this paper
• Improvement of stability and dissolution of prostaglandin E1 by maltosyl-beta-cyclodextrin in lyophilized formulation.

  1992cited by this paper
• EFFECTS OF CYCLODEXTRINS ON N-TRIFLUOROACETYLDOXORUBICIN-14-VALERATE (AD-32) STABILITY AND SOLUBILITY IN AQUEOUS MEDIA

  1991cited by this paper
• A simple assay for lipid hydroperoxides based on triphenylphosphine oxidation and high-performance liquid chromatography

  1991cited by this paper
• Effect of cyclodextrin complexation on the chemical stability of doxorubicin and daunorubicin in aqueous solutions

  1991cited by this paper
• Effect of Autoxidation of Hydrogenated Castor Oil Containing 60 Oxyethylene Groups on Degradation of Miconazole.

  1991cited by this paper
• Transition metals as catalysts of "autoxidation" reactions.

  1990cited by this paper
• Drug-Excipient Incompatibility Studies of the Dipeptide Angiotensin-Converting Enzyme Inhibitor, Moexipril Hydrochloride: Dry Powder vs Wet Granulation

  1990cited by this paper
• The chemistry of the Maillard reaction under physiological conditions: a review.

  1989cited by this paper
• The chemistry of the Maillard reaction under physiological conditions: a review.

  1989cited by this paper
• In: Ullmann''''s Encyclopedia of Industrial Chemistry

  1989cited by this paper
• Inhibitors of endogenous nitrosation. Mechanisms and implications in human cancer prevention.

  1988cited by this paper
• Improvement of chemical instability of prostacyclin in aqueous solution by complexation with methylated cyclodextrins

  1987cited by this paper
• Drug excipient interaction, effect of adsorption of oxytetracycline hydrochloride by some tablet excipients on the physiological availability of the tablets

  1987cited by this paper
• Antioxidants in pharmaceutical products.

  1982cited by this paper
• Drug--disintegrant interactions: binding of oxymorphone derivatives.

  1981cited by this paper
• Autoxidation of polyoxyethylenic non-ionic surfactants and of polyethylene glycols.

  1975cited by this paper
• [Granulation of acetylsalicylic acid by a wet process. Influence of pH and some adjuvants for stabilization].

  1975cited by this paper
• Reaction of haloperidol with 5-(hydroxymethyl)-2-furfuraldehyde, an impurity in anhydrous lactose.

  1974cited by this paper
• Interaction of dextroamphetamine sulfate with spray-dried lactose.

  1972cited by this paper
• Polyvinylpyrrolidone (PVP), its diagnostic, therapeutic and technical application and consequences thereof.

  1971cited by this paper
• Photodegradation of polyethylene film

  1968cited by this paper
• Comparison of reactivity of amphetamine, methamphetamine, and dimethylamphetamine with lactose and related compounds.

  1965cited by this paper
• BROWNING OF SPRAY-PROCESSED LACTOSE.

  1964cited by this paper
• Preliminary report on the comparative stability of certified colorants with lactose in aqueous solution.

  1963cited by this paper
• Complex formation influence on reaction rate. I. Effect of caffeine on riboflavin base-catalyzed degradation rate.

  1962cited by this paper
• Inhibition of hydrolysis of esters in solution by formation of complexes. III. Stabilization of tetracaine with caffeine.

  1957cited by this paper
• Scientific EditionInhibition of Hydrolysis of Esters in Solution Formation of Complexes III.*: Stabilization of Tetracaine with Caffeine

  1957cited by this paper
• Inhibition of hydrolysis of esters in solution by formation of complexes. IV. Stabilization of benzocaine with 1-ethyltheobromine.

  1957cited by this paper
• Inhibition of hydrolysis of esters in solution by formation of complexes. II. Stabilization of procaine with caffeine.

  1956cited by this paper
• Inhibition of hydrolysis of esters in solution by formation of complexes. I. Stabilization of benzocaine with caffeine.

  1955cited by this paper
• The Amadori rearrangement.

  1955cited by this paper

• Impact of manufacturing process, lot-to-lot variations and storage stability on the free radical generation in pharmaceutical polymer (polyvinylpyrrolidone)

  2026cites this paper
• Pharmacoinformatics in Drug-Excipient Interactions.

  2025cites this paper
• An Enhanced and Highly Sensitive LC-MS-Based Analytical Approach for the Quantitative Determination of Carcinogenic N-Nitrosopiperazine in Cetirizine Dihydrochloride.

  2025cites this paper
• Quantification of Hydrogen Peroxide in PVP and PVPVA Using 1H qNMR Spectroscopy

  2025cites this paper
• Nitrosamine Drug Substance-Related Impurities (NDSRIs) in Pharmaceuticals: Formation, Mitigation Strategies, and Emphasis on Mutagenicity Risks

  2025influential citation
• Metal-induced oxidation of polysorbate 80 in the presence of hydrogen peroxide: mechanistic studies.

  2025cites this paper
• Nitrite Testing in Excipients - Industry Best Practices.

  2025cites this paper
• Theorizing Critical Locus of Supply: A Material Flow Perspective

  2025cites this paper
• Safety assessment of antibody-drug conjugates: nonclinical toxicology, non-active ingredients, and environmental risk considerations.

  2025cites this paper
• Impact of peroxide content in excipients and antioxidants on famotidine oxidative stability

  2025cites this paper
• Review on the modern analytical advancements in impurities testing

  2025cites this paper
• High-Throughput Determination of Trace-Level Peroxides in Reagents and Packaging Materials Based on a Simple 96-Well Plate Ultraviolet Spectrometric Method

  2025cites this paper
• Pediatric formulations and challenges beyond technological development: Identification and in silico qualification of impurities in 5 mg primaquine tablets.

  2025cites this paper
• Advanced characterization of frovatriptan degradation products using 2D NMR and LC-HRMS/MS: Integrative stability and forced degradation analysis to uncover novel impurities

  2025cites this paper
• Formulation and optimization of chrysin emulgel using 32 factorial design of emulsifying and gelling agent for enhanced topical delivery

  2025cites this paper
• DFT studies for searching of anti-microbial excipients for the novel formulation of clindamycin

  2025cites this paper
• A New Analytical LC–MS/MS Method for Determination of Eight Standard Nitrosamines (NDMA, NMBA, NDEA, NEIPA, NDIPA, NMPA, NDPA, NDBA) in a Commercial Small Molecule Drug Product Capsules and its Active Pharmaeceutical Ingredient for Treatment of Fabry: A Rare Disease

  2025cites this paper
• Instrumental investigations and preformulation study of the progestin drug desogestrel

  2025cites this paper
• Mechanisms of polysorbate 80 oxidation: Acetate and Fe(III) mediated near UV and visible light degradation enhanced by free fatty acids.

  2025cites this paper
• One-pot HPLC method for simultaneous quantification of hydrogen peroxide and organic peroxides

  2025cites this paper
• Excipients in drug delivery systems: A comprehensive review of approved inactive ingredients for human ophthalmic formulations.

  2025cites this paper
• Determination of glucose impurities in glucose-salt complex pharmaceutical products by HPLC-RID method: Analytical method development and validation study.

  2025cites this paper
• Development and Optimization of Eberconazole Nanostructured Lipid Carrier Topical Formulations Based on the QbD Approach

  2025cites this paper
• Drug Substance and Drug Product Workflows for Quality Risk Management for the Presence of Nitrosamines in Medicines

  2025cites this paper
• Preliminary Study on the Development of Orodispersible Film Containing Desloratadine.

  2025cites this paper
• Monitoring the Concentration of Nitrogen Oxides in the Fluidized Bed Drying/Granulation Process and Evaluation of Reduction Methods.

  2025cites this paper
• Understanding the impact of excipient variability on oral solid dosage form performance: a possible role for multivariate data analysis, in the form of principal component analysis.

  2025cites this paper
• N-Nitrosamine Formation in Pharmaceutical Drug Products: Development and Validation of a Biased, Conservative, Predictive Model.

  2025cites this paper
• Review on LC-MS/MS Methodologies for Analysis of N-Nitrosamine Drug-Substance-Related Impurities.

  2025cites this paper
• Effect of drugs for chronic non-communicable diseases on the in vitro bioaccessibility of micronutrients (Cu, Fe, Mn, and Zn) in nutritive flours (amaranth, oat, quinoa and soybean) from Brazil

  2025cites this paper
• Safety assessment of drug impurities for patient safety: a comprehensive review.

  2024cites this paper
• Investigation of the Influence of Copovidone Properties and Hot-Melt Extrusion Process on Level of Impurities, In Vitro Release, and Stability of an Amorphous Solid Dispersion Product.

  2024cites this paper
• Analytical Artifact Due to Residual HCN in Acetonitrile: Identification and Control Strategies

  2024cites this paper
• Risk of Formaldehyde Contamination in Amines from Residual Dichloromethane

  2024cites this paper
• Reactivity of N terminal Histidine of Peptides towards Excipients/Impurity of Excipients: A Case Study of Liraglutide Excipient Compatibility Study.

  2024cites this paper
• Analytical Methodologies to Detect N‑Nitrosamine Impurities in Active Pharmaceutical Ingredients, Drug Products and Other Matrices

  2024cites this paper
• Enhanced Stability and Compatibility of Montelukast and Levocetirizine in a Fixed-Dose Combination Monolayer Tablet

  2024cites this paper
• Risk-Based Approach for Defining Retest Dates for Active Pharmaceutical Ingredients and Excipients

  2024cites this paper
• Probing Short-Range Interactions in Isostructural Hydrate and Perhydrate of Dabrafenib by Magic-Angle Spinning Solid-State NMR.

  2024cites this paper
• Unveiling the Superiority of Innovative Carbonated Self-Nanoemulsifying Drug Delivery Systems in Improving the Stability of Acid-Labile Drugs: Atorvastatin as a Model Drug

  2024cites this paper
• Quantification of Nitrite in Excipients and Chemicals: A Versatile and Highly Sensitive Method Using Headspace Gas Chromatography Coupled to Mass Spectrometry

  2024cites this paper
• Assessing Drug Product Shelf Life Using the Accelerated Stability Assessment Program: A Case Study of a GLPG4399 Capsule Formulation

  2024cites this paper
• Structure Identification and Risk Assurance of Unknown Impurities in Pramipexole Oral Drug Formulation

  2024cites this paper
• A headspace GC-MS method to quantify nitrosamine impurities and precursors in drug products: Method validation and product testing.

  2024cites this paper
• The Impact of UV Radiation on the Hemispherical Reflectance Values and Homogeneity of Tablets Containing Clindamycin and Phenoxymethylpenicillin

  2024cites this paper
• Nitrosamine mitigation: NDMA impurity formation and its inhibition in metformin hydrochloride tablets.

  2024cites this paper
• MICROCRYSTALLINE CELLULOSE: A BIOPOLYMER WITH DIVERSIFORM APPLICATIONS

  2024cites this paper
• Identification, Synthesis, and Characterization of N-Formyl Mirabegron: A New Degradation Product Formed by Formic Acid Impurity in Pharmaceutical Excipients

  2024cites this paper
• Detection of impurities in acetaminophen intravenous and oral formulations: Health-risk assessment

  2024cites this paper
• A comprehensive UPLC-MS/MS method for the determination of N-nitroso metamizole EP impurity C in metamizole drug products

  2024cites this paper
• Nitrosated active pharmaceutical ingredients - lessons learned?

  2023cites this paper
• Impact of formaldehyde, acetaldehyde, and N-(3-(Dimethylamino)propyl)methacrylamide on the efficacy of the human derived coagulation factor IX.

  2023cites this paper
• A comprehensive review of sources of nitrosamine contamination of pharmaceutical substances and products.

  2023cites this paper
• Nitrosamine Impurities: Assessing Concerns through Case Studies

  2023cites this paper
• Regulatory Experiences with Root Causes and Risk Factors for Nitrosamine Impurities in Pharmaceuticals.

  2023cites this paper
• Polymer-inducing chemical degradation of amorphous solid dispersions driven by drug-polymer interactions for physical stabilization.

  2023cites this paper
• Why mRNA-ionizable LNPs formulations are so short-lived: causes and way-out

  2023cites this paper
• Structural modifications for the conversion of proteins and peptides into stable dried powder formulations: A review

  2023cites this paper
• Analytical method development, validation, and out-of-specification investigations for polyethylene glycol.

  2023cites this paper
• Effect of Excipients on the Quality of Drug Formulation and Immediate Release of Generic Metformin HCl Tablets

  2023cites this paper
• Multifunctional low temperature-cured PVA/PVP/citric acid-based hydrogel forming microarray patches: Physicochemical characteristics and hydrophilic drug interaction

  2023cites this paper
• Identification of Two Novel Hydroperoxide Impurities in Fluocinolone Acetonide Topical Solution by Liquid Chromatography Mass Spectrometry.

  2023cites this paper
• N-Nitrosamine Formation in Pharmaceutical Solid Drug Products: Experimental Observations.

  2023cites this paper
• Analytical method validation for tenofovir alafenamide and known impurities

  2023cites this paper
• Purification processes of polymeric nanoparticles: How to improve their clinical translation?

  2023cites this paper
• Formation of N-Nitrosamine Drug Substance Related Impurities in Medicines: A Regulatory Perspective on Risk Factors and Mitigation Strategies

  2023cites this paper
• Systematic Screening Study for the Selection of Proper Stabilizers to Produce Physically Stable Canagliflozin Nanosuspension by Wet Milling Method

  2023cites this paper
• Fisher Digital

  2023cites this paper
• Development of Child-Friendly Lisdexamfetamine Chewable Tablets Using Ion Exchange Resin as a Taste-Masking Carrier Based on the Concept of Quality by Design (QbD)

  2023cites this paper
• Quantitation of Reactive Nitrosating Agents in Pharmaceutical Excipients for N-Nitrosamine Risk Assessments

  2023cites this paper
• Bumetanide as a Model NDSRI Substrate: N-nitrosobumetanide impurity formation and its inhibition in bumetanide tablets.

  2023cites this paper
• Solid State Kinetics of Nitrosation Using Native Sources of Nitrite.

  2023cites this paper
• Study of Oncolytic Virus Preservation and Formulation

  2023cites this paper
• Thermodynamic modelling of the nature of speciation and phase behaviour of binary and ternary mixtures of formaldehyde, water and methanol

  2023cites this paper
• The quality of drugs and drug products - Always guaranteed?

  2023cites this paper
• Sodium Starch Glycolate (SSG) from Sago Starch (Metroxylon sago) as a Superdisintegrant: Synthesis and Characterization

  2023cites this paper
• N-nitrosamine mitigation with nitrite scavengers in oral pharmaceutical drug products.

  2023cites this paper
• Development and Validation of Headspace-Gas Chromatography (HS-GC) Method for the Determination of Potential Genotoxic Impurities in Meloxicam

  2023cites this paper
• On-column trace-level formation of N-nitrosamine in a liquid chromatography-mass spectrometry analytical system.

  2023cites this paper
• Nitroso Impurities in Drug Products: An Overview of Risk Assessment, Regulatory Milieu, and Control Strategy

  2023cites this paper
• NDMA formation due to active ingredient degradation and nitrite traces in drug product.

  2023cites this paper
• Correlation of endocrine disrupting chemicals with essential elements in biological samples of children (1-5 years) with different infectious diseases and impact on sustainable outdoor activities.

  2023cites this paper
• Theoretical and Experimental Investigation of Autoxidation Propensity of Selected Drugs in Solution State.

  2023cites this paper
• Nitrosamine impurities in pharmaceutical dosage forms: Current challenges and mitigation strategies

  2023cites this paper
• Impact of concerning excipients on animal safety: insights for veterinary pharmacotherapy and regulatory considerations

  2023cites this paper
• Current threat of nitrosamines in pharmaceuticals and scientific strategies for risk mitigation.

  2023cites this paper
• Development and Optimization of Stability-Indicating Method of Solifenacin Succinate and its Main Product of Degradation in Tablet Dosage form using the Quality by Design Approach

  2023cites this paper
• Drug-Excipient Compatibility Study Through a Novel Vial-in-Vial Experimental Setup: A Benchmark Study

  2023cites this paper
• Root cause analysis regarding formation of N-nitrosodimethylamine impurity in drug product containing API with reactive amines

  2022cites this paper
• Polymeric hydrogel forming microneedle-mediated transdermal delivery of sildenafil citrate from direct-compressed tablet reservoir for potential improvement of pulmonary hypertension therapy.

  2022cites this paper
• The role of titanium dioxide (E171) and the requirements for replacement materials in oral solid dosage forms: An IQ Consortium Working Group Review.

  2022cites this paper
• Oxidative degradation in pharmaceuticals: Mechanism and stabilization of a spray-dried amorphous drug - A case study.

  2022cites this paper
• A simple non-linear kinetic model to evaluate stability of a pressure sensitive drug.

  2022cites this paper
• Reconsidering the Safety Hazards Associated with Peroxide Formation in 2-Propanol

  2022cites this paper
• Chromatographic fractionation of food-grade oligosaccharides: Recognizing and avoiding sensory-relevant impurities.

  2022cites this paper
• N-Nitrosation in the absence of nitrosating agents in pharmaceuticals?

  2022cites this paper
• Visible Light Induces Site-Specific Oxidative Heavy Chain Fragmentation of a Monoclonal Antibody (IgG1) Mediated by an Iron(III)-Containing Histidine Buffer.

  2022cites this paper
• Forced Solid-State Oxidation Studies of Nifedipine-PVP Amorphous Solid Dispersion.

  2022cites this paper
• Avoiding N-Nitrosodimethylamine Formation in Metformin Pharmaceuticals by Limiting Dimethylamine and Nitrite.

  2022cites this paper
• Formaldehyde analysis of seized cosmetic products by HS-GC-MS of methylal, ethoxymethoxymethane, and ethylal derivatives

  2022cites this paper